Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Pediatric Surgery|August 1, 1996
Long-term pulmonary sequelae in survivors of congenital diaphragmatic defectsK Vanamo, R Rintala, A Sovijärvi, et al.
Pediatric Pulmonology|October 27, 1999
Intraindividual variability of infant whole-body plethysmographic measurements: effects of age and diseaseL P Malmberg, A Pelkonen, A Hakulinen, et al.
Nutrition Research (New York, N.Y.)|May 12, 2012
Plant sterols and casein-derived tripeptides attenuate blood pressure increase in spontaneously hypertensive ratsPauliina I Ehlers, Anne S Kivimäki, Aino Siltari, et al.
Chest|December 18, 2001
Acceptability, reproducibility, and sensitivity of forced expiratory volumes and peak expiratory flow during bronchial challenge testing in asthmatic childrenL P Malmberg, K Nikander, A S Pelkonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymesM Hidestrand, M Oscarson, J S Salonen, et al.
Journal of Dairy Science|July 4, 2025
Tolerance of protein-hydrolyzed lactose-free A1 milk and A2 milk in lactose-tolerant and lactose-intolerant volunteers: A randomized crossover trial with 2 parallel groupsEnni Mannila, Liisa Hokkanen, Eija Ahonen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 1, 1996
Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatmentsR Sorva, R Tähtelä, M Turpeinen, et al.
The American Journal of Clinical Nutrition|August 29, 2002
Bioconversion of vaccenic acid to conjugated linoleic acid in humansAnu M Turpeinen, Marja Mutanen, Antti Aro, et al.
Nutrients|April 25, 2019
Protein Supplements and Their Relation with Nutrition, Microbiota Composition and Health: Is More Protein Always Better for Sportspeople?Anna Kårlund, Carlos Gómez-Gallego, Anu M Turpeinen, et al.
British Journal of Pharmacology|February 28, 2007
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysisL E Korhonen, M Turpeinen, M Rahnasto, et al.
Pageof 9